Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study

OBJECTIVE: To gather preliminary data on the feasibility and efficacy of etanercept therapy to prolong endogenous insulin production in pediatric patients with newly diagnosed type 1 diabetes. RESEARCH DESIGN AND METHODS: This was a 24-week double-blind, randomized, placebo-controlled study conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastrandrea, Lucy, Yu, Jihnhee, Behrens, Torsten, Buchlis, John, Albini, Christine, Fourtner, Shannon, Quattrin, Teresa
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699714/
https://www.ncbi.nlm.nih.gov/pubmed/19366957
http://dx.doi.org/10.2337/dc09-0054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699714/
https://www.ncbi.nlm.nih.gov/pubmed/19366957
http://dx.doi.org/10.2337/dc09-0054

Ejemplares similares